ACOTEC-B(06669) released its mid-term financial performance with a net profit of 88.577 million yuan, representing a year-on-year increase of 121.7%.

26/08/2025

Sino Biopharmaceutical Limited (06669) released its performance for the six months ending on June 30, 2025. During the period, the group achieved...

ACOTEC-B (06669) released its performance for the six months ending June 30, 2025. The group made a revenue of 351 million RMB during the period, an increase of 20.1% compared to the previous year. The net profit for the period was 88.577 million RMB, a 121.7% increase compared to the previous year. The basic earnings per share was 0.29 RMB.

BLOKS (00325) plans to buy back company shares.

Fujian Holdings (00181) announced its interim results, with a net profit attributable to shareholders of HKD 18.66 million, reversing the loss to a profit on a year-on-year basis.

China New Energy (01156) announces its interim results. The company's owners' share of the loss amounted to 7.852 million yuan, an increase of 184.49% year-on-year.

BLOKS (00325) plans to buy back company shares.

Fujian Holdings (00181) announced its interim results, with a net profit attributable to shareholders of HKD 18.66 million, reversing the loss to a profit on a year-on-year basis.

China New Energy (01156) announces its interim results. The company's owners' share of the loss amounted to 7.852 million yuan, an increase of 184.49% year-on-year.